Service Corporation Revenue Mix: What's Powering the Top Line?

SCI's Q3 revenue rose 4.4% as cemetery preneed gains outweighed mixed funeral trends, reshaping the company's top-line mix.

• Fri, 09 Jan 2026 09:00:47
• Zacks Investment Research

SHEL Expects Higher Output in Q4 Despite Lower Oil Trading Performance

Shell estimates higher Q4 2025 oil and gas output, but warns oil trading will be significantly weaker as crude prices slide.

• Fri, 09 Jan 2026 09:00:46
• Zacks Investment Research

Nvidia Vs Broadcom: Which AI Stock To Bet On?

Broadcom experienced a decline of -17% over the past month. You might feel inclined to purchase more shares or perhaps consider decreasing your investment.

• Fri, 09 Jan 2026 09:00:31
• Forbes

Norsemont Provides 2025 Year-End Update and Appoints New CFO

Vancouver, B.C. - TheNewswire - January 9, 2026 – Norsemont Mining Inc. (CSE: NOM, OTC: NRRSF, FWB: LXZ1) ( “ Norsemont ” or the “ Company ”) is pleased to provide a corporate update highlighting 2025 milestones and upcoming initiatives at its 100%-owned Choquelimpie project in northern Chile having recently raised $15 million from new and existing strategic investors. The Choquelimpie project is a past-producing gold-silver mine with historical heap leach production. On April 14, 2025, the Company published its initial mineral resource estimate of 2,184,000 indicated gold-equivalent ounces and 557,000 inferred gold-equivalent ounces in oxide stockpiles and deeper sulfides . The project benefits from extensive infrastructure including power, water, road access, camp facilities, and a 3,000 tonne-per-day mill. positioning it for rapid advancement toward production. Gold-Equivalent (AuEq) ounces (oz) have been calculated using a gold (Au) price of US$2,500/oz, silver (Ag) price of US$28/oz and copper (Cu) price of US$4.00/pound; and according to the following formula: AuEq oz = Au oz + (ozAg*AgPrice/AuPrice) + (CuGrade*CuPrice/AuPrice).

• Fri, 09 Jan 2026 09:00:00
• TheNewswire

Ocumetics Announces Transition of Chief Medical Officer Consulting Role

Calgary, Alberta – TheNewswire - January 9, 2026 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in next generation ophthalmic technology, today announced that it intends to form a Scientific Advisory Committee (SAC) to fill the role now being performed by a single Chief Medical Officer.  In the result, the consulting agreement with the Corporation's current Chief Medical Officer, Dr. Doyle Stulting, will terminate following a ninety-day transition period. As Ocumetics advances toward completion of its First-in-Human (FIH) study and prepares for a pivotal FDA clinical trial anticipated in 2027, the Company is evolving its medical and clinical leadership structure to align with its next exciting phase of growth and execution. The transition is from a single CMO structure to a broader multi-member Scientific Advisory Committee (SAC) structure. This committee will provide deeper and more diverse medical, clinical, and regulatory oversight as the Company advances toward late-stage clinical development.

• Fri, 09 Jan 2026 09:00:00
• TheNewswire

Retirees Should Give Fidelity's Forgotten Emerging Markets ETF a Look Right Now

Emerging markets climbed over 25% in 2025 while trading at deep discounts to U.S.

• Fri, 09 Jan 2026 08:58:08
• 24/7 Wall Street

Omai Gold Grants Incentive Stock Options

Toronto, Ontario--(Newsfile Corp. - January 9, 2026) - Omai Gold Mines Corp. (TSXV: OMG) (OTCQB: OMGGF) ("Omai Gold" or the "Company") announces that it has granted incentive stock options to Officers, Directors, employees and consultants of the Company to purchase up to 10,720,000 common shares of the Company pursuant to the Company's stock option plan. The options have a five-year term at an exercise price of $1.44 per share, with one third vesting upon the date of grant, one third on the first anniversary of the date of grant and the final third on the second anniversary of the date of grant with an expiry date of January 8, 2031.

• Fri, 09 Jan 2026 08:57:00
• Newsfile Corp

3 Construction & Mining Equipment Stocks to Watch Despite Industry Headwinds

The Zacks Industry Rank for the Manufacturing - Construction and Mining industry paints a dull picture. We believe that stocks like CAT, TEX and ASTE are still worth a look.

• Fri, 09 Jan 2026 08:55:13
• Zacks Investment Research

Senti Bio to Participate in Panel Presentation at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that Dr. Timothy Lu, Co-Founder and CEO, will participate as a panelist alongside Jonah Comstock, Editor in Chief, pharmaphorum; Jay Hartenbach, President & COO, Diakonos Oncology; George Magrath CEO, Opus Genetics; Kate Rochlin COO, IN8bio; and Amber Salzman CEO, Epicrispr Biotechnologies at Biotech Showcase 2026, taking place January 12–14, 2026, in San Francisco, CA.

• Fri, 09 Jan 2026 08:55:00
• GlobeNewsWire

Magnera to Report First Quarter Results on February 5th

CHARLOTTE, N.C., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Magnera (NYSE: MAGN) expects to release its first quarter results prior to trading on the New York Stock Exchange on Thursday, February 5, 2026. The earnings release, along with an investor presentation, will be available shortly thereafter on Magnera's website at Investor Relations – Magnera.

• Fri, 09 Jan 2026 08:54:00
• GlobeNewsWire

AAR Corporation: A Quality Aerospace Stock Still Trading Below What It Deserves

AAR Corporation: A Quality Aerospace Stock Still Trading Below What It Deserves

• Fri, 09 Jan 2026 08:53:17
• Seeking Alpha

Jensen Huang Says Humanoid Robots are Coming This Year. Which Physical AI Stocks are Best-Positioned?

The rise of the robotics revolution and “physical AI” could keep the AI trade alive and well through 2026 and even into 2027.

• Fri, 09 Jan 2026 08:53:09
• 24/7 Wall Street

Can AI-Driven DRAM Demand Sustain Micron's Revenue Upswing?

MU is riding on an AI-fueled DRAM boom as higher memory content, pricing gains and tight supply drive revenue growth.

• Fri, 09 Jan 2026 08:50:20
• Zacks Investment Research

3 Ways Dividend Investors Can Benefit From The AI Trend In 2026

AI stole the spotlight, but dividend investors still have ways to benefit. You do not need tech stocks to profit from the AI boom. Three overlooked income plays linked to AI growth.

• Fri, 09 Jan 2026 08:50:00
• Seeking Alpha

Taiwan Semiconductor Started 2nm Chip Production. Time to Buy?

Taiwan Semiconductor Manufacturing (NYSE:TSM) shares have been unstoppable in the past year, gaining more than 52%, thanks in part to a handful of incredible quarters.

• Fri, 09 Jan 2026 08:49:28
• 24/7 Wall Street

Metals Creek Acquires 0.5 % NSR on the Tillex Property from Blue Moon Metals Inc. (formerly Savant Explorations Ltd.)

Thunder Bay, Ontario--(Newsfile Corp. - January 9, 2026) - Metals Creek Resources Corp. (TSXV: MEK) (FSE: M1C1) (the "Company" or Metals Creek) is pleased to announce that the Company has acquired the 0.5% Net Smelter Royalty (NSR) from Blue Moon Metals Inc. (Blue Moon), (formerly Savant Explorations Ltd. ("Savant")) on the Tillex property located in Currie Township, 65 km east of Timmins, Ontario.

• Fri, 09 Jan 2026 08:49:00
• Newsfile Corp

Oklo's stock surges. Why Meta's new nuclear bet is so significant.

Meta Platforms is betting big on nuclear energy to satisfy the insatiable appetite of its artificial-intelligence supercomputers.

• Fri, 09 Jan 2026 08:49:00
• Market Watch

Cerro de Pasco Resources Provides Operational Review, Project Progress and Corporate Update

MONTREAL, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Cerro de Pasco Resources Inc. (TSXV CDPR) (OTCQB GPPRF) (FRA N8HP) (the Company or CDPR) is pleased to provide an operational review and corporate update highlighting key workstreams completed and consolidated at the Quiulacocha Tailings Project, as the Company transitions toward the next stage of project execution.

• Fri, 09 Jan 2026 08:48:00
• GlobeNewsWire

Spot gold shoots to $4,490/oz after U.S. housing starts fall -4.6% in September, -0.2% in October

Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.

• Fri, 09 Jan 2026 08:47:02
• Kitco

Here's What We Expect From AbbVie's Immunology Segment in Q4

ABBV's Q4 outlook hinges on surging Skyrizi and Rinvoq demand, as investors watch immunology sales to offset Humira's past loss of exclusivity.

• Fri, 09 Jan 2026 08:46:08
• Zacks Investment Research

Kratos Defense Stock Rises 35.3% in a Month: Here's How to Play

KTOS has jumped 35.3% in a month on contract wins and rising unmanned system demand, but weaker ROIC and sector risks complicate the entry timing.

• Fri, 09 Jan 2026 08:46:07
• Zacks Investment Research

Tempus AI Stock Surges 82.4% in a Year: What's Driving It?

TEM shares are up 82.4% in a year as Genomics revenues surge, Data & Services scale, FDA clearances and EBITDA turns positive.

• Fri, 09 Jan 2026 08:46:05
• Zacks Investment Research

FIDU: Industrials Sector 2026 Outlook Is Promising, Upside Is Ahead

Fidelity MSCI Industrials Index ETF is rated a buy with a $102 price target, implying nearly 20% upside. FIDU is positioned to benefit from accelerating US industrials sector growth, driven by robust GDP expansion and anticipated rate cuts in 2026. The ETF offers broad exposure across 363 companies, with strong contributions from aerospace, defense, and transportation leaders like GE, RTX, and BA.

• Fri, 09 Jan 2026 08:45:22
• Seeking Alpha

SCHD: Is There Life After Broadcom?

SCHD remains a top choice for income-focused investors, despite recent underperformance after dropping Broadcom in its 2024 rebalance. SCHD's underperformance was driven by the loss of AVGO as well as rising rates, highlighting SCHD's concentration risk and sensitivity to macro conditions. SCHD's core strength is its sustainable, above-market dividend yield (~3 to 4% historically), outperforming peers like VYM on income but not on total return.

• Fri, 09 Jan 2026 08:45:00
• Seeking Alpha

PDS Biotech Announces FDA Alignment on use of Progression Free Survival (PFS) as Primary Endpoint

PDS Biotech Submits Amended Protocol for Phase 3 VERSATILE-003 Trial Constructive Type C Meeting Provides Potential Pathway to Accelerated Approval of PDS0101 PRINCETON, N.J., Jan. 09, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced that the Company has submitted a protocol amendment to the U.S. Food & Drug Administration (“FDA”) for its Phase 3 VERSATILE-003 clinical trial.

• Fri, 09 Jan 2026 08:45:00
• GlobeNewsWire

Autonomix Showcases Compelling PoC Study Clinical Data Showing Rapid and Durable Pain Relief Across All Disease Stages of Pancreatic Cancer at the 2026 ASCO Gastrointestinal (GI) Cancers Symposium

New subgroup analysis shows consistent, clinically meaningful pain reduction observed from Stage 2 through Stage 4 disease, including late-stage patients with otherwise limited treatment options

• Fri, 09 Jan 2026 08:45:00
• GlobeNewsWire

Marriott International Announces Changes to its Continent Leadership and a Strategic Realignment Across Key Regions

Unified structure for U.S., Canada & CALA under Satya Anand's leadership; Neal Jones to lead EMEA; Federico "Fede" Greppi to head CALA; retirements of Marriott veterans Liam Brown and Brian King announced. BETHESDA, Md.

• Fri, 09 Jan 2026 08:45:00
• PRNewsWire

Paranovus Entertainment Technology Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement

NEW YORK, Jan. 9, 2026 /PRNewswire/ -- Paranovus Entertainment Technology Limited (NASDAQ: PAVS) today announced that on January 6, 2026, it received notification from the Nasdaq Office of General Counsel stating that the Company had regained compliance with the bid price requirement as set forth in Listing Rule 5550(a)(2) and that Company is therefore in compliance with the Nasdaq Capital Market's listing requirements. As a result, the scheduled hearing before the Hearings Panel on January 29, 2026 had been cancelled and the matter was closed.

• Fri, 09 Jan 2026 08:45:00
• PRNewsWire

General Motors records $7.1B in Q4 charges as EV demand slows

General Motors Company (NYSE:GM) said Thursday it will record $7.1 billion in special charges for the fourth quarter of 2025, reflecting a pullback in its electric vehicle (EV) strategy and restructuring efforts tied to its operations in China. In a filing with the Securities and Exchange Commission (SEC), the Detroit automaker said approximately $6 billion of the charges are related to changes in its EV plans amid weakening demand in North America.

• Fri, 09 Jan 2026 08:44:02
• Proactive Investors

Bunge: A New Era Of Agribusiness Dominance

Bunge Global SA offers compelling value post-Viterra merger, trading at a 12.7x forward P/E and a discount to ADM. BG's integration with Viterra enhances global logistics operational 'granularity' and positions the company for margin expansion and cash flow growth. Guidance remains firm with FY adjusted EPS of $7.30–$7.60, and 2026 is expected to reveal substantial synergy benefits and a potential 20% upside.

• Fri, 09 Jan 2026 08:41:59
• Seeking Alpha

Gold prices attracting some new bullish attention after U.S. economy created 50k jobs in December

Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.

• Fri, 09 Jan 2026 08:41:16
• Kitco

Lamb Weston Streamlines Global Footprint to Improve Efficiency

LW plans to close its Munro plant in Argentina, shift Latin America output to Mar del Plata and curb a Netherlands line to cut costs and boost efficiency.

• Fri, 09 Jan 2026 08:41:07
• Zacks Investment Research

Crude Oil Price Outlook – Crude Attempting to Break Resistance

The light sweet crude oil market has fallen a bit in the early hours of Friday trading, along with the Brent market. However, both have now turned around and are threatening a breakout.

• Fri, 09 Jan 2026 08:39:47
• FXEmpire

Marks & Spencer holds the line as food strength offsets clothing wobble

The latest trading update from Marks and Spencer Group PLC (LSE:MKS), released on Thursday, painted a familiar picture: solid progress in food doing the heavy lifting, while clothing remains the swing factor. According to Deutsche Bank, the key takeaway is that full-year profit guidance has been held, despite third-quarter sales coming in a little softer than hoped.

• Fri, 09 Jan 2026 08:35:15
• Proactive Investors

Cool Company Ltd. Announces Completion of Merger with Wholly Owned Subsidiary of EPS Ventures Ltd.

LONDON--(BUSINESS WIRE)--Reference is made to the stock exchange announcement published by Cool Company Ltd. (“CoolCo” or the “Company”) (NYSE: CLCO / CLCO.OL) on January 6, 2026, announcing that all conditions precedent to the completion of the merger of CoolCo with a newly formed, wholly owned subsidiary of EPS Ventures Ltd. (“EPS”) have been satisfied. The merger has been duly registered in the Bermuda Registrar of Companies, having been effected through a cash merger. The merger has now bee.

• Fri, 09 Jan 2026 08:35:00
• Business Wire

FEPI Somehow Gives You 25% Income Off Big Tech Stocks That Hardly Pay Dividends

REX FANG & Innovation Equity Premium Income ETF ( NYSEARCA:FEPI ) delivers a 25% annual distribution from tech stocks that barely pay dividends.

• Fri, 09 Jan 2026 08:33:17
• 24/7 Wall Street

JBS N.V. Reminds Investors of Upcoming Expiration Date of Its Registered Exchange Offers

Amstelveen, Netherlands, Jan. 09, 2026 (GLOBE NEWSWIRE) -- JBS N.V. (the “Company,” “JBS,” “we” or “us”) (NYSE: JBS; B3: JBSS32), reminds the holders of Old Notes (as defined below) that each Exchange Offer (as defined below) will expire  at 5:00 p.m., New York City time, on Monday, January 12, 2026 , unless extended (the “Expiration Date”).

• Fri, 09 Jan 2026 08:33:00
• GlobeNewsWire

Crude Oil "Sell the Rip," Gold & Big Tech "Buy the Dip"

Ahead of Friday's December jobs report, @ProsperTradingAcademy's Scott Bauer weighs in on market movers to watch into the end of the trading week. For crude oil, he considers any move higher on the commodity a "sell the rip" move until fundamentals change and demand rises.

• Fri, 09 Jan 2026 08:30:21
• Schwab Network

Insider Buying: Bonk, Inc. Board Member Mitchell Rudy Acquires Stock to Close Q4

BONK Co-Founder and Director Purchase Signals Continued Confidence in Company's "Revenue-to-Treasury" Strategy Heading into 2026 SCOTTSDALE, ARIZONA / ACCESS Newswire / January 9, 2026 / Bonk, Inc. (Nasdaq:BNKK) today announced that Mitchell Rudy (a.k.a. Nom), a member of the Company's Board of Directors and a core contributor to the BONK ecosystem, executed an open-market purchase of 13,142 shares of Bonk, Inc. common stock at the close of the fourth quarter.

• Fri, 09 Jan 2026 08:30:00
• Accesswire

Brenmiller Energy Founder & CEO Avi Brenmiller Wins Merage Industry Leader Award

Recognition Honors Leadership Behind a Landmark Clean-Energy Exit and Decades of Industry Impact ROSH HA'AYIN, ISRAEL / ACCESS Newswire / January 9, 2026 / Brenmiller Energy Ltd. ("Brenmiller", "Brenmiller Energy" or the "Company") (Nasdaq:BNRG), a leading global provider of Thermal Energy Storage ("TES") solutions for industrial and utility customers, today announced that Avi Brenmiller, Founder and Chief Executive Officer of Brenmiller Energy, has been honored with the Merage DeserTech Industry Leader Award.

• Fri, 09 Jan 2026 08:30:00
• Accesswire

Bitmine Appoints Chief Financial Officer and Chief Operating Officer

Finance, VC and engineering veteran, Young Kim, joins dual role as CFO and COO, effective immediately Bitmine now owns 3.43% of the ETH token supply, two-thirds of the way to the 'Alchemy of 5%' Bitmine will hold its Annual Stockholder Meeting at the Wynn Las Vegas on January 15, 2026 Bitmine is supported by a premier group of institutional investors including ARK's Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, and Galaxy Digital to support Bitmine's goal of acquiring 5% of ETH: The alchemy of 5% LAS VEGAS, Jan. 9, 2026 /PRNewswire/ -- (NYSE AMERICAN: BMNR) Bitmine Immersion Technologies, Inc. ("Bitmine" or the "Company") today announced that Young Kim has been appointed Chief Financial Officer ("CFO") and Chief Operating Officer ("COO") in addition to being appointed as a member of the Company's Board of Directors (the "Board"). Mr. Kim will report to Thomas "Tom" Lee, Chairman of the Board.

• Fri, 09 Jan 2026 08:30:00
• PRNewsWire

Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2025 Net Revenue

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio, today announced its preliminary, unaudited net revenue for the fourth quarter and full-year ended December 31, 2025. The preliminary unaudited results described in this press release are based on the most current information available to management and are subject to change until the audit of the company's 2025 financial results is completed a.

• Fri, 09 Jan 2026 08:30:00
• Business Wire

Manhattan Associates Announces Latest Enhancements for Retailers

ATLANTA--(BUSINESS WIRE)--Manhattan announces major enhancements to Manhattan Active® Omni.

• Fri, 09 Jan 2026 08:30:00
• Business Wire

Galiano Gold Provides Notice of Fourth Quarter and Full Year 2025 Results

Vancouver, British Columbia--(Newsfile Corp. - January 9, 2026) - Galiano Gold Inc. (TSX: GAU) (NYSE American: GAU) ("Galiano" or the "Company") is pleased to announce it will release its fourth quarter ("Q4") and full year ("FY") 2025 financial and operational results after market close on February 12, 2026. The Company will host a conference call and webcast to review the Q4 and FY results on February 13, 2026, at 7:30am PT.

• Fri, 09 Jan 2026 08:30:00
• Newsfile Corp

2 Mega Dividends Designed To Reward Loyalty; Yields +7.5%

Good businesses reward loyal customers with discounts and offers. They reward loyal shareholders with growing dividends. In investing, consistency and patience result in strong compounded returns. We discuss two picks that prioritize steady, repeatable distributions, offering yields of up to 12.5%.

• Fri, 09 Jan 2026 08:30:00
• Seeking Alpha

SEALSQ and Kaynes SemiCon Reach Final Agreement to Develop a Sovereign Indian Post-Quantum Semiconductor Joint Venture in Alignment with MeitY

Geneva, Switzerland, Jan. 09, 2026 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, and a subsidiary of WISeKey International Holding AG (Nasdaq: WKEY; SIX: WIHN) (“WISeKey”), today announced that it has reached a final, binding agreement with Kaynes SemiCon to establish SEALKAYNESQ Ltd, a Joint Venture (“JV”) in India. The JV is being formed with the objective of developing, personalizing, and deploying a Sovereign Indian Post-Quantum semiconductor platform, fully aligned with India's national digital sovereignty and security priorities, and developed in direct dialogue with India's Ministry of Electronics and Information Technology (MeitY), the central authority responsible for India's electronics, IT, cybersecurity, and emerging-technology strategy.

• Fri, 09 Jan 2026 08:30:00
• GlobeNewsWire

Perma-Fix Environmental Services Receives Expanded Permit for Richland Facility, Approximately Tripling Liquid Mixed Waste Processing Capacity

Permit Renewal Increases Potential Throughput to Approximately 1.2 Million Gallons Annually and Strengthens Long-Term Strategic Positioning at Perma-Fix Northwest Permit Renewal Increases Potential Throughput to Approximately 1.2 Million Gallons Annually and Strengthens Long-Term Strategic Positioning at Perma-Fix Northwest

• Fri, 09 Jan 2026 08:30:00
• GlobeNewsWire

Nutanix to Present at Upcoming Investor Conference

SAN JOSE, Calif., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Nutanix , Inc. (NASDAQ: NTNX ), a leader in hybrid multicloud computing, today announced that its management will present at the following upcoming financial community event: 28 th Annual Needham Growth Conference Friday, January 16, 20268:00 a.m.

• Fri, 09 Jan 2026 08:30:00
• GlobeNewsWire

CG Oncology Provides Updated Timeline for PIVOT-006 Phase 3 Topline Data in Intermediate-Risk NMIBC

- PIVOT-006 Phase 3 topline data evaluating cretostimogene monotherapy for intermediate-risk NMIBC now expected in 1H 2026, nearly one year ahead of schedule

• Fri, 09 Jan 2026 08:30:00
• GlobeNewsWire

Tenaya Therapeutics Announces 2026 Strategic Priorities and Anticipated Milestones

Aims to Build on Positive 2025 Interim TN-201 Results in First Half of 2026 with  Longer-Term Follow-Up Data for Cohorts 1 and 2 from MyPEAK™-1 Trial of Adults with MYBPC3-Associated HCM

• Fri, 09 Jan 2026 08:30:00
• GlobeNewsWire

Clene Announces Registered Direct Offering of Over $28 Million

Oversubscribed registered direct offering priced above market to new, existing and insider investors, including Boxer Capital Management, Coastlands Capital, and Vivo Capital Initial financing tranche of over $6 million, which we expect will provide cash runway into the third quarter of 2026 enabling funding through potential NDA acceptance decision by the FDA, with two additional financing tranches totaling over $22 million contingent on NDA acceptance and NDA approval by the FDA Completion of this financing through its three tranches is expected to provide the Company with sufficient capital into early 2027, which we expect will allow potential commercialization of CNM-Au8 in ALS SALT LAKE CITY, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene” or the “Company”) and its wholly owned subsidiary, Clene Nanomedicine, Inc., a late clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS), today announced a registered direct offering priced above market under Nasdaq rules of over $28 million by new and existing investors. “We are happy to welcome top-tier investors Boxer Capital, Coastlands Capital and Vivo Capital, along with other current insider investors, who share our excitement and enthusiasm for the important work that Clene has undertaken in ALS,” said Rob Etherington, CEO of Clene, Inc. “Their investment further validates the promise and potential of ALS biomarkers and survival data for a planned New Drug Application in ALS in 2026 for CNM-Au8, on which Clene has been focused.

• Fri, 09 Jan 2026 08:30:00
• GlobeNewsWire

Lexicon Pharmaceuticals Publishes “Relief is Possible: Ensuring Access to Effective Treatments for Chronic Pain”

-White Paper based on October 2025 Roundtable of diverse stakeholders focused on accelerating innovation and expanding access to novel non-opioid therapies- -Need for swift action by policymakers to support millions of Americans suffering from chronic pain- THE WOODLANDS, Texas, Jan. 09, 2026 (GLOBE NEWSWIRE) -- In October 2025, Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) convened an in-person Roundtable in Washington, D.C., to better understand the unmet needs of people living with chronic pain and identify what more can be done to benefit patients and society at large.

• Fri, 09 Jan 2026 08:30:00
• GlobeNewsWire

Scienjoy Holding Corporation Granted Additional 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

BEIJING, Jan. 9, 2026 /PRNewswire/ -- Scienjoy Holding Corporation ("Scienjoy", the "Company", or "we") (NASDAQ: SJ), an interactive entertainment leader in the Chinese market, today announced that on January 7, 2026, it received notification from The Nasdaq Stock Market LLC ("Nasdaq") that Nasdaq approved the Company's request for an additional 180-calendar day extension (the "Extension") to regain compliance with the minimum closing bid price requirement of US$1.00 per share, as set forth in Nasdaq Listing Rule 5550(a)(2) (the "Rule"). The Extension follows the expiration on January 6, 2026 of the initial 180-calendar day period to regain bid price compliance.

• Fri, 09 Jan 2026 08:30:00
• PRNewsWire

Youlife Group Inc. Announces A Strategic Partnership With Sealand Maritime Service Co., Ltd. to Build a New Talent Ecosystem for High-end Cruise Tourism Services

BEIJING, Jan. 9, 2026 /PRNewswire/ -- Youlife Group Inc. ("Youlife" or the "Company") (NASDAQ: YOUL), a leading blue-collar lifetime service provider in China, today announced that it has entered into a joint venture agreement with Sealand Maritime Service Co., Ltd. ("Sealand"), a leading cruise crew recruitment and dispatch company in China.

• Fri, 09 Jan 2026 08:30:00
• PRNewsWire

NRSInsights' December 2025 Retail Same-Store Sales Report

December same-store sales increased 4.5% year-over-year  The average price paid for the top 500 items in December increased 2.3% year-over-year NEWARK, N.J., Jan. 09, 2026 (GLOBE NEWSWIRE) -- NRSInsights, a provider of sales data and analytics drawn from retail transactions processed through the National Retail Solutions (NRS) point-of-sale (POS) platform, today announced comparative retail same-store sales results for December 2025.

• Fri, 09 Jan 2026 08:30:00
• GlobeNewsWire

Royalty Pharma Announces Dividend Increase

NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that its board of directors has declared a dividend for the first quarter of 2026 of $0.235 per Class A ordinary share, reflecting a 6.8% increase in the company's quarterly dividend over the previous quarter's dividend. The dividend will be paid on March 10, 2026 to shareholders of record at the close of business on February 20, 2026.

• Fri, 09 Jan 2026 08:30:00
• GlobeNewsWire

CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

BERKELEY HEIGHTS, N.J., Jan. 09, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that Joseph Todisco, Chairman and CEO of CorMedix Therapeutics, will present a corporate overview at the 44th annual J.P. Morgan Healthcare Conference. The presentation is scheduled to take place on Monday, January 12, 2026 at 4:30pm PST.

• Fri, 09 Jan 2026 08:30:00
• GlobeNewsWire

Riley Permian Declares Quarterly Dividend

OKLAHOMA CITY, Jan. 9, 2026 /PRNewswire/ -- Riley Exploration Permian, Inc. (NYSE American: REPX) ("Riley Permian" or the "Company") today announced that its Board of Directors has approved a cash dividend on the Company's common stock in the amount of $0.40 per share. The dividend is payable on February 5, 2026, to stockholders of record as of the close of business on January 22, 2026.

• Fri, 09 Jan 2026 08:30:00
• PRNewsWire

Fidelis Insurance Group Schedules Fourth Quarter 2025 Financial Results Conference Call

PEMBROKE, Bermuda--(BUSINESS WIRE)--Fidelis Insurance Holdings Limited (NYSE:FIHL) ("Fidelis Insurance Group", the “Group” or the "Company"), a global specialty insurer and reinsurer, announced today that it expects to release financial results for the fourth quarter ended December 31, 2025, on February 25, 2026, after the close of the financial markets. These documents will be available via the Investors section of the Company's website at https://investors.fidelisinsurance.com. Dan Burrows, G.

• Fri, 09 Jan 2026 08:30:00
• Business Wire

Here's Why I'll Keep Buying SoFi Stock In 2026

In this video, I will cover the recent updates regarding SoFi (SOFI +2.67%). Watch the short video to learn more, consider subscribing, and click the special offer link below.

• Fri, 09 Jan 2026 08:30:00
• The Motley Fool

NANO Nuclear Energy Announces Dismissal of Federal Securities Lawsuit

Dismissal of Federal Securities Class Action Lawsuit Follows Dismissal of Related Shareholder Derivative Lawsuit New York, New York--(Newsfile Corp. - January 9, 2026) - NANO Nuclear Energy Inc. (NASDAQ: NNE) ("NANO Nuclear" or "the Company"), a leading advanced nuclear micro modular reactor (MMR) and technology company focused on developing clean energy solutions, announced today that the United States District Court for the Southern District of New York granted NANO Nuclear's motion to dismiss the putative securities class action lawsuit filed against Nano Nuclear and certain of its officers and directors. The lawsuit, captioned Hongui Xie v.

• Fri, 09 Jan 2026 08:29:00
• Newsfile Corp

Karman Holdings CEO Sells Insider Shares For Four Consecutive Weeks

For four consecutive weeks, ending on Dec. 12, 2025, Karman Holdings' CEO sold insider shares. The chief executive sold over 200,000 shares within that span.

• Fri, 09 Jan 2026 08:28:55
• The Motley Fool

Prediction: SPDR's Euro ETF Is Just Heating Up

After a decade of trailing the S&P 500, European equities are finally having their moment.

• Fri, 09 Jan 2026 08:27:29
• 24/7 Wall Street

SLP Stock Crashes on Q1 Earnings Miss, Software Headwinds Hurt Sales

Simulations Plus Q1 fiscal 2026 EPS miss as software revenue fall 17%, but services momentum and strong bookings support confidence for the rest of fiscal 2026.

• Fri, 09 Jan 2026 08:25:27
• Zacks Investment Research

How To Earn $500 A Month From Bank of America Stock Ahead Of Q4 Earnings

Investors are turning their focus to Bank of America‘s (NYSE: BAC) dividend as the lender heads into its upcoming earnings report.

• Fri, 09 Jan 2026 08:25:26
• Benzinga

The Best Stocks to Buy With $1,000 Right Now

The consumer staples sector has gained 1.5% over the past year, compared to a 17% increase for the S&P 500 index. There was an interesting performance reversal that occurred over this past year.

• Fri, 09 Jan 2026 08:25:00
• The Motley Fool

2026 Global Outlook May Create Moments for Active ETFs

What should advisors and investors expect for the global economy through 2026? Given the many macroeconomic factors at play, figuring out the best path forward is not straightforward.

• Fri, 09 Jan 2026 08:21:45
• ETF Trends

As Global Defense Spending Surges, This ETF Could Shine

The new year is still in its infancy. However, as the U.S. incursion against Venezuela confirms, geopolitical events are already front-and-center.

• Fri, 09 Jan 2026 08:21:44
• ETF Trends

Spice up Crypto Trading in 2026 With This Exciting ETF

If there's one thing experienced investors know about the crypto realm, it's that the arena doesn't lack for excitement. They also know that sentiment cuts both ways.

• Fri, 09 Jan 2026 08:21:43
• ETF Trends

Meta's New AI Glasses See “Unprecedented Demand”—What's Next?

Meta Platforms NASDAQ: META just provided an interesting update on its latest artificial intelligence (AI) glasses. In September of last year, the Magnificent Seven company unveiled its next-generation AI device, the Meta Ray-Ban Display.

• Fri, 09 Jan 2026 08:21:33
• MarketBeat

Southwest Airlines Stock Gets a Rare Double Upgrade. Why It's Suddenly a Buy.

The carrier's potential earnings per share guidance is generating plenty of excitement on Wall Street.

• Fri, 09 Jan 2026 08:20:00
• Barrons

Energy Transfer: Game Changing FY26 Guidance

Energy Transfer's 2026 EBITDA guidance of $17.3-17.7 billion is exceptionally strong and shows their growth strategy is working. Energy Transfer's disappointing 2025 performance was largely due to a weaker commodity pricing environment and switching to longer term contracts in its Intrastate segment. By 2027, Energy Transfer's distributable cash flow could reach $10.5-11 billion, enough to fund the current distribution almost 2.5 times over.

• Fri, 09 Jan 2026 08:18:08
• Seeking Alpha

ITGR LEGAL NOTICE: Integer Holdings Corporation Investors are Encouraged to Contact BFA Law before the Upcoming February 9 Securities Fraud Class Action Deadline

New York, New York--(Newsfile Corp. - January 9, 2026) - Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Integer Holdings Corporation (NYSE: ITGR) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Integer, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/integer-holdings-corporation-class-action-lawsuit.

• Fri, 09 Jan 2026 08:18:00
• Newsfile Corp

FRMI LEGAL NOTICE: Fermi Inc. Investors are Encouraged to Contact BFA Law before the Upcoming March 6 Securities Fraud Class Action Deadline

New York, New York--(Newsfile Corp. - January 9, 2026) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Fermi Inc. (NASDAQ: FRMI), certain of the Company's senior executives and directors, and underwriters of Fermi's Initial Public Offering after a significant stock drop resulting from potential violations of the federal securities laws. If you invested in Fermi, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/fermi-inc-class-action-lawsuit.

• Fri, 09 Jan 2026 08:18:00
• Newsfile Corp

BRBR LEGAL NOTICE: BellRing Brands Investors are Encouraged to Contact BFA Law to Protect Your Rights in Ongoing Class Action Investigation

New York, New York--(Newsfile Corp. - January 9, 2026) - Leading international securities law firm Bleichmar Fonti & Auld LLP announces an investigation into BellRing Brands, Inc. (NYSE: BRBR) for potential violations of the federal securities laws. If you invested in BellRing, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/bellring-brands-inc-class-action-lawsuit.

• Fri, 09 Jan 2026 08:18:00
• Newsfile Corp

ARE LEGAL NOTICE: Alexandria Real Estate Equities, Inc. Investors are Encouraged to Contact BFA Law Before the Upcoming January 26 Securities Fraud Class Action Deadline

New York, New York--(Newsfile Corp. - January 9, 2026) - Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. (NYSE: ARE) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Alexandria Real Estate, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/alexandria-real-estate-class-action-lawsuit.

• Fri, 09 Jan 2026 08:18:00
• Newsfile Corp

ARDT LEGAL NOTICE: Ardent Health, Inc. Investors are Notified BFA Law has Filed a Class Action Lawsuit and Urges Investors to Contact the Firm by March 9 Deadline

New York, New York--(Newsfile Corp. - January 9, 2026) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a class action lawsuit against Ardent Health, Inc. (NYSE: ARDT) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from potential violations of the federal securities laws. If you invested in Ardent Health, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-health-inc-class-action-lawsuit.

• Fri, 09 Jan 2026 08:18:00
• Newsfile Corp

LRN LEGAL NOTICE: Stride, Inc. Investors are Encouraged to Contact BFA Law before the Upcoming January 12 Securities Fraud Class Action Deadline

New York, New York--(Newsfile Corp. - January 9, 2026) - Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Stride, Inc. (NYSE: LRN) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws. If you invested in Stride, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/stride-inc-class-action-lawsuit.

• Fri, 09 Jan 2026 08:18:00
• Newsfile Corp

Enterprise Products Up 6% in a Year: Time to Bet on the Stock or Wait?

EPD beat its industry with a 6% yearly gain, backed by inflation-linked contracts and capital returns, but valuation and leverage argue for patience.

• Fri, 09 Jan 2026 08:16:05
• Zacks Investment Research

MySize Inc. Advances AI Roll-Up Strategy in Retail and Fashion Through Targeted Acquisition Focus

TEL AVIV, Israel and NEW YORK, Jan. 9, 2026 /PRNewswire/ -- MySize, Inc. (NASDAQ: MYSZ), a provider of AI-powered technology solutions for the global retail and fashion industries, today announced that it is advancing its strategic initiative to build a scalable AI-driven platform through the identification and potential acquisition of complementary technology companies. The Company's strategy is centered on a disciplined "AI roll-up" approach, focused on selectively acquiring businesses with proven technologies, proprietary data assets, and established customer relationships that can be efficiently integrated into MySize's existing ecosystem.

• Fri, 09 Jan 2026 08:15:00
• PRNewsWire

EpicQuest Education Awarded CES Speed Award for Global Branding

The Award Recognizes the Company's Internationalization Strategy that Exports its Academic Programs and Pioneers Initiatives that Integrate AI into Higher Education TOLEDO, Ohio, Jan. 9, 2026 /PRNewswire/ -- EpicQuest Education Group International Limited (Nasdaq: EEIQ), ("EpicQuest Education," or the "Company"), a provider of higher education for domestic and international students in the US, Canada and the UK, today announced that it has been awarded the CES Speed Award for Global Branding at CES 2026, the world's largest global technology event held in Las Vegas. The award is a signature initiative presented by Attencity Marketing and SMG, CES's exclusive China media partner.

• Fri, 09 Jan 2026 08:15:00
• PRNewsWire

MoonLake: Positive FDA Meeting Spurs Momentum Ahead Of BLA Submission

MoonLake regains momentum after the FDA Type B meeting allows BLA submission for sonelokimab in HS without additional trials. MLTX is de-risked, with a BLA submission targeted for 2H26, removing a major regulatory overhang and accelerating the timeline. Sonelokimab's existing Phase 2 MIRA and Phase 3 VELA data now form the basis for regulatory submission, supporting efficacy and safety.

• Fri, 09 Jan 2026 08:15:00
• Seeking Alpha

If You'd Invested $10,000 in This Nuclear Energy ETF 1 Year Ago, You Might Be Surprised How Much You'd Have Today

The VanEck Uranium and Nuclear ETF beat the market in 2025. The ETF could be poised to see more growth in 2026.

• Fri, 09 Jan 2026 08:15:00
• The Motley Fool

Enbridge's Reliable Business Model Supports Attractive Dividend Growth

ENB's fee-based midstream model drives stable earnings, billions in secured projects and a 5.94% yield, supporting projected dividend growth through 2026.

• Fri, 09 Jan 2026 08:11:07
• Zacks Investment Research

Amazon (NASDAQ: AMZN) Stock Price Prediction in 2030: Bull, Bear, & Baseline Forecasts (Jan 9)

Amazon.com Inc. (NASDAQ: AMZN) has been one of the stock market's biggest success stories ever.

• Fri, 09 Jan 2026 08:10:58
• 24/7 Wall Street

Gold price up, silver sharply up; it's jobs Friday, and maybe more

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

• Fri, 09 Jan 2026 08:10:48
• Kitco

Adobe: I'm Pounding The Table On This Unloved Compounder (Rating Upgrade)

Adobe Inc. is a high-quality compounder trading at its most attractive valuation since the early 2010s. Despite competitive pressures from Figma and generative AI, ADBE maintains strong double-digit revenue and profit growth, complemented by aggressive share buybacks. Shares now trade at 19.8x earnings and 5.8x sales, well below historical averages, offering compelling long-term upside.

• Fri, 09 Jan 2026 08:09:47
• Seeking Alpha

flyExclusive Announces Pricing of $15 Million Public Offering of Common Stock

KINSTON, N.C.--(BUSINESS WIRE)--flyExclusive, Inc. (NYSE American: FLYX) (the “Company” or “flyExclusive”), one of the nation's leading private aviation operators, today announced the pricing of its previously announced underwritten public offering of 2,255,639 shares of its common stock at a public offering price of $6.65 per share of common stock, before deducting underwriting discounts and commissions and offering expenses. Lucid Capital Markets is acting as the sole book-running manager for.

• Fri, 09 Jan 2026 08:08:00
• Business Wire

Orion Digital Corp. Announces Monetization of Remaining WonderFi Investment, Strengthening Balance Sheet

VANCOUVER, British Columbia--(BUSINESS WIRE)--Orion Digital Corp. (NASDAQ: ORIO; TSX: ORIO) (“Orion Digital” or the “Company”), a founder-led digital finance platform operating primarily across wealth, payments, and digital assets, today announced that it exited its remaining equity position in WonderFi Technologies Inc. (“WonderFi”), increasing the Company's cash and cash equivalents by more than 50% over Q3 2025 to approximately CDN$27 million. The monetization comes after the previously anno.

• Fri, 09 Jan 2026 08:08:00
• Business Wire

AeroVironment (AVAV) Surges 8.3%: Is This an Indication of Further Gains?

AeroVironment (AVAV) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

• Fri, 09 Jan 2026 08:05:57
• Zacks Investment Research

Is Sterling's E-Infrastructure Segment the Real Growth Star?

STRL's E-Infrastructure segment drives outsized growth as data center demand lifts revenue, backlog and visibility.

• Fri, 09 Jan 2026 08:05:56
• Zacks Investment Research

Astronics (ATRO) Moves 11.3% Higher: Will This Strength Last?

Astronics (ATRO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

• Fri, 09 Jan 2026 08:05:55
• Zacks Investment Research

Nvidia (NASDAQ: NVDA) Bull, Base, & Bear Stock Price Prediction and Forecast (Jan 9)

The trade war with China was tough on Nvidia Corp. (NASDAQ: NVDA) investors.

• Fri, 09 Jan 2026 08:05:47
• 24/7 Wall Street

Form 8.3 - Unite Group Plc

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION (a)   Full name of discloser: Rathbones Group Plc (b)   Owner or controller of interests and short positions disclosed, if different from 1(a):         The naming of nominee or vehicle companies is insufficient.

• Fri, 09 Jan 2026 08:05:00
• GlobeNewsWire

GigaCloud Technology Inc to Participate in 28th Annual Needham Growth Conference

EL MONTE, Calif., Jan. 09, 2026 (GLOBE NEWSWIRE) -- GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B technology solutions for large parcel merchandise, today announced that Larry Wu, its Founder and Chief Executive Officer, will present at the 28t h Annual Needham Growth Conference on Friday, January 16, 2026, at 2:15 p.m. ET/11:15 a.m. PT.

• Fri, 09 Jan 2026 08:05:00
• GlobeNewsWire

Cellectar Biosciences to Highlight Strategic Initiatives for 2026 at Upcoming Biotech Showcase during 44th Annual JP Morgan Healthcare Conference

Following Guidance from the European Medicines Agency's (EMA) Scientific Advice Working Party (SAWP) Regarding Iopofosine I 131 for the Treatment of Waldenstrom's Macroglobulinemia (WM), Expects to Submit for Conditional Marketing Approval in Europe in 3Q 2026

• Fri, 09 Jan 2026 08:05:00
• GlobeNewsWire

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., Jan. 9, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. ("Rigel") (Nasdaq: RIGL) today announced that it has granted awards pursuant to the Rigel Pharmaceuticals, Inc. Inducement Plan, approved by the Compensation Committee of Rigel's Board of Directors and granted as an inducement material to employees entering into employment with Rigel, in accordance with NASDAQ Listing Rule 5635(c)(4).

• Fri, 09 Jan 2026 08:05:00
• PRNewsWire

Aptevo Therapeutics Secures $60 Million Equity Line of Credit to Support Multispecific Portfolio Advancement, Increase Strategic Optionality

Together with cash on hand, the fully leveraged facility extends Aptevo's funding runway into 2029, enabling achievement of key clinical and preclinical milestones SEATTLE, WA / ACCESS Newswire / January 9, 2026 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology Company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR® and ADAPTIR-FLEX® platform technologies, today announced that the Company has entered into a $60 million equity line of credit (ELOC) agreement with Yorkville Advisors Global, LP, strengthening the Company's financial flexibility as it continues to advance its clinical and preclinical pipeline of multispecific anti-cancer agents that are differentiated by design. The facility provides Aptevo with access to capital, allowing the Company to raise funds incrementally, at its discretion, and under market-based conditions.

• Fri, 09 Jan 2026 08:05:00
• Accesswire

Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH) (“Delcath” or the “Company”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced preliminary financial results and business updates for the fourth quarter and year-ended December 31, 2025. Preliminary Fourth Quarter and Full-Year 2025 Financial Results (unaudited) Total fourth quarter and full year revenue expected to be approximately $20.7 million and.

• Fri, 09 Jan 2026 08:05:00
• Business Wire

Cartesian Therapeutics Highlights Recent Progress and Outlines 2026 Outlook

Enrollment on track in Phase 3 AURORA trial of Descartes-08 in myasthenia gravis  IND application for Descartes-08 in myositis accepted by FDA; seamless adaptive clinical trial offering potential opportunity for a single pivotal trial expected to commence in 1H26 Phase 1/2 pediatric trial of Descartes-08 in juvenile dermatomyositis initiated Cash resources expected to support planned operations, including completion of planned Phase 3 trial for Descartes-08 for myasthenia gravis, into mid-2027 FREDERICK, Md., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today highlighted its recent progress and outlined its 2026 strategic priorities across its cell therapy pipeline targeting autoimmune diseases.

• Fri, 09 Jan 2026 08:04:00
• GlobeNewsWire